NYSE: CRHCrh Public Ltd Co Stock
$94.94+0.47 (+0.5%)
Updated Jul 3, 2025
CRH Price
$94.94
Fair Value Price
N/A
Market Cap
$64.18B
52 Week Low
$74.02
52 Week High
$110.97
P/E
19.95x
P/B
3.04x
P/S
1.66x
PEG
1.3x
Dividend Yield
0.39%
Revenue
$35.80B
Earnings
$3.28B
Gross Margin
35.6%
Operating Margin
13.93%
Profit Margin
9.2%
Debt to Equity
1.4
Operating Cash Flow
$5B
Beta
1.15
Next Earnings
Aug 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CRH Overview
CRH plc is the parent of companies that manufacture building materials and operate builders' supply and 'Do-It-Yourself' stores. Offerings include cement, aggregates, ready-mixed concrete, asphalt/bitumen, and agricultural and/or chemical lime. Resulting from the 1970 merger of Cement Limited and Roadstone Limited, CRH plc is headquartered in Dublin, Ireland.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CRH's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Building Material
Industry Rating
D
CRH
Ranked#8 of 15
Ranked#8 of 15
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $104.80 | B | |
| $78.04 | B | |
| $11.31 | C |
Be the first to know about important CRH news, forecast changes, insider trades & much more!
CRH News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CRH scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CRH ($94.94) is trading above its intrinsic value of $52.92, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CRH is good value based on its earnings relative to its share price (19.95x), compared to the US market average (30.96x)
P/E vs Market Valuation
CRH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CRH due diligence checks available for Premium users.
Valuation
CRH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
19.95x
Industry
26.74x
Market
30.96x
CRH is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CRH is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CRH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.04x
Industry
2.58x
CRH is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CRH price to earnings growth (PEG)
For valuing profitable companies with growth potential
CRH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CRH's financial health
Profit margin
Revenue
$6.8B
Net Income
-$94.0M
Profit Margin
-1.4%
CRH's Earnings (EBIT) of $4.99B... subscribe to Premium to read more.
Interest Coverage Financials
CRH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$51.9B
Liabilities
$29.6B
Debt to equity
1.4
CRH's short-term assets ($14.24B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRH's long-term liabilities ($20.85B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$659.0M
Investing
-$964.0M
Financing
$1.1B
CRH's operating cash flow ($5.04B)... subscribe to Premium to read more.
Debt Coverage Financials
CRH vs Building Material Stocks
Crh Public Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.